Sepsis-Induced Immunosuppression in Neonates

Area of Science:

• Neonatal immunology
• Infectious disease
• Inflammation research

Background:

• Neonates, particularly preterm infants, face high risks of sepsis and long-term complications from infection-related inflammation.
• Neonatal immune responses are distinct, leading to unique susceptibilities to sepsis and inflammation.
• The traditional view of sepsis progression (hyper-inflammation followed by hypo-inflammation) is evolving, with new evidence suggesting inflammation can fluctuate.

Purpose of the Study:

• To investigate the role of sepsis-induced immunosuppression (SII) in neonatal sepsis outcomes.
• To determine if the immune characteristics of SII observed in adults are present in neonates with sepsis.
• To enhance understanding of neonatal immune responses during sepsis.

Main Methods:

• Literature review focusing on neonatal sepsis and adult sepsis-induced immunosuppression.
• Comparative analysis of immune alterations in adult and neonatal sepsis.
• Exploration of key characteristics of sepsis-induced immunosuppression in neonates.

Main Results:

• Evidence suggests mortality in early sepsis is linked to hyper-inflammation.
• Emerging data in adults indicate that hypo- and hyper-inflammation can occur anytime during sepsis.
• Sepsis-induced immunosuppression in adults involves altered innate and adaptive immunity, impacting T cells and cytokine profiles.

Conclusions:

• The role of sepsis-induced immunosuppression in adverse neonatal sepsis outcomes remains unclear.
• Further research is needed to confirm if adult SII characteristics manifest in neonates.
• Understanding neonatal SII is crucial for improving sepsis management and long-term outcomes.